FindTrial
Sign In

Development of patient-reported Outcomes (PRO) scale after androgen deprivation therapy (ADT) for prostate cancer

Development of patient-reported Outcomes (PRO) scale after androgen deprivation therapy (ADT) for prostate cancer

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500095463
Enrollment
Unknown
Registered
2025-01-07
Start date
2025-01-15
Completion date
Unknown
Last updated
2025-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Prostate cancer

Interventions

Observation group:none

Sponsors

Department of Urology, Xiyuan Hospital, China Academy of Chinese Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
Male
Age
45 Years to 90 Years

Inclusion criteria

Inclusion criteria: (1) men aged 45 years and above and under 90 years; (2) Patients with clinical diagnosis of PCa and receiving ADT therapy for >=3 months (3) Patients who fully understand and voluntarily participate in this study

Exclusion criteria

Exclusion criteria: 1. Combined with other serious diseases, serious condition is not suitable to participate in the researcher. 2. Have serious mental or mental illness, or aphasia, cognitive impairment, unable to communicate normally.

Design outcomes

Primary

MeasureTime frame
Reliability and validity;—

Countries

China

Contacts

Public ContactGao Zhan

Xiyuan Hospital, China Academy of Chinese Medical Sciences

gaozhanmd@vip.163.com+86 139 1087 1852

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026